| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K49290616 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.8 |
| mRNA | BRD-K11533227 | CTRPv2 | pan-cancer | AAC | 0.0079 | 0.8 |
| mRNA | erismodegib | CTRPv2 | pan-cancer | AAC | 0.0079 | 0.8 |
| mRNA | ML006 | CTRPv2 | pan-cancer | AAC | 0.0078 | 0.8 |
| mRNA | BRD8958 | CTRPv2 | pan-cancer | AAC | -0.0081 | 0.8 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | -0.016 | 0.8 |
| mRNA | TPCA-1 | CTRPv2 | pan-cancer | AAC | 0.0065 | 0.8 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | -0.0073 | 0.8 |
| mRNA | CHEMBL374350 | CTRPv2 | pan-cancer | AAC | -0.0075 | 0.8 |
| mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | 0.0071 | 0.8 |